NASDAQ:QDELQuidel Stock Price, Forecast & News

Quidel's stock was trading at $89.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, QDEL shares have increased by 93.5% and is now trading at $173.49. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Quidel.

Quidel is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Quidel.

Quidel Co. (NASDAQ:QDEL) posted its quarterly earnings data on Wednesday, February, 12th. The company reported $1.00 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.82 by $0.18. The company earned $152.20 million during the quarter, compared to the consensus estimate of $148 million. Quidel had a return on equity of 23.69% and a net margin of 15.73%. Quidel's revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.80 EPS. View Quidel's earnings history.

5 brokers have issued twelve-month target prices for Quidel's shares. Their forecasts range from $75.00 to $170.00. On average, they expect Quidel's stock price to reach $117.00 in the next twelve months. This suggests that the stock has a possible downside of 32.6%. View analysts' price targets for Quidel.

Media stories about QDEL stock have trended somewhat positive this week, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Quidel earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutQuidel.

Quidel saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,800,000 shares, an increase of 40.7% from the April 15th total of 1,990,000 shares. Based on an average trading volume of 522,400 shares, the short-interest ratio is presently 5.4 days. Currently, 7.6% of the shares of the stock are short sold. View Quidel's Current Options Chain.

Some companies that are related to Quidel include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO), Antares Pharma (ATRS) and Anika Therapeutics (ANIK). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include NVIDIA (NVDA), Shopify (SHOP), Netflix (NFLX), Teladoc Health (TDOC), Trade Desk (TTD), Alibaba Group (BABA), Gilead Sciences (GILD), Twilio (TWLO), Adobe (ADBE) and Okta (OKTA).

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (11.34%), BlackRock Inc. (6.26%), Fred Alger Management LLC (4.83%), ArrowMark Colorado Holdings LLC (2.11%), State Street Corp (2.07%) and New York State Common Retirement Fund (1.61%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View institutional ownership trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including Brown Capital Management LLC, ArrowMark Colorado Holdings LLC, Investment Management of Virginia LLC, Gabelli Funds LLC, Morgan Stanley, Massachusetts Financial Services Co. MA, New York State Common Retirement Fund, and Rothschild & Co. Asset Management US Inc.. Company insiders that have sold Quidel company stock in the last year include Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, and Werner Kroll. View insider buying and selling activity for Quidel.

QDEL stock was bought by a variety of institutional investors in the last quarter, including Fred Alger Management LLC, Invesco Ltd., GW&K Investment Management LLC, JPMorgan Chase & Co., Sandler Capital Management, Federated Hermes Inc., Mackay Shields LLC, and Geode Capital Management LLC. View insider buying and selling activity for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $173.49.

Quidel has a market capitalization of $7.29 billion and generates $534.89 million in revenue each year. The company earns $72.92 million in net income (profit) each year or $2.73 on an earnings per share basis. Quidel employs 1,250 workers across the globe.

The official website for Quidel is www.quidel.com.

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at 858-552-1100 or via email at [email protected]